We have focused on the detection of novel biomarkers of cancer progression including of invasion and metastasis based on experimental studies [2] and have identified the S100 family proteins S100A14 and S100A16 as important candidate molecules for the regulation of metastatic disease. Here, S100A14 is linked to cancer.